ICON Public Limited Company (ICLR)
USD 204.4
(0.56%)
USD 204.4
(0.56%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.81 Billion USD | -18.07% |
| 2022 | 2.21 Billion USD | 46.82% |
| 2021 | 1.5 Billion USD | 86.65% |
| 2020 | 808.03 Million USD | -2.85% |
| 2019 | 831.7 Million USD | 8.09% |
| 2018 | 769.49 Million USD | 5.85% |
| 2017 | 726.96 Million USD | 3.09% |
| 2016 | 705.15 Million USD | 5.88% |
| 2015 | 665.99 Million USD | 10.97% |
| 2014 | 600.14 Million USD | 22.32% |
| 2013 | 490.64 Million USD | 23.63% |
| 2012 | 396.87 Million USD | 18.89% |
| 2011 | 333.8 Million USD | -6.93% |
| 2010 | 358.65 Million USD | -5.57% |
| 2009 | 379.82 Million USD | 1.02% |
| 2008 | 376.01 Million USD | 36.12% |
| 2007 | 276.24 Million USD | 38.58% |
| 2006 | 199.33 Million USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 134.36 Million USD | 30.0% |
| 2003 | 103.35 Million USD | 41.22% |
| 2002 | 73.18 Million USD | 39.76% |
| 2001 | 52.36 Million USD | 35.22% |
| 2000 | 38.72 Million USD | 46.12% |
| 1999 | 26.5 Million USD | -37.05% |
| 1998 | 42.1 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 591.41 Million USD | 24.01% |
| 2024 Q2 | 476.92 Million USD | 1.51% |
| 2024 Q1 | 469.83 Million USD | -0.2% |
| 2023 Q1 | 583.03 Million USD | 0.29% |
| 2023 FY | 1.81 Billion USD | -18.07% |
| 2023 Q4 | 470.78 Million USD | -22.31% |
| 2023 Q2 | 590.71 Million USD | 1.32% |
| 2023 Q3 | 605.96 Million USD | 2.58% |
| 2022 FY | 2.21 Billion USD | 46.82% |
| 2022 Q1 | 523.29 Million USD | -0.86% |
| 2022 Q2 | 543.13 Million USD | 3.79% |
| 2022 Q3 | 566.59 Million USD | 4.32% |
| 2022 Q4 | 581.32 Million USD | 2.6% |
| 2021 FY | 1.5 Billion USD | 86.65% |
| 2021 Q1 | 231.95 Million USD | 3.14% |
| 2021 Q4 | 527.81 Million USD | 3.82% |
| 2021 Q3 | 508.41 Million USD | 111.81% |
| 2021 Q2 | 240.03 Million USD | 3.48% |
| 2020 Q4 | 224.88 Million USD | 7.95% |
| 2020 Q3 | 208.31 Million USD | 19.45% |
| 2020 FY | 808.03 Million USD | -2.85% |
| 2020 Q2 | 174.39 Million USD | -16.88% |
| 2020 Q1 | 209.8 Million USD | -3.41% |
| 2019 Q2 | 204.48 Million USD | 2.57% |
| 2019 Q1 | 199.35 Million USD | -0.23% |
| 2019 Q3 | 210.65 Million USD | 3.02% |
| 2019 FY | 831.7 Million USD | 8.09% |
| 2019 Q4 | 217.21 Million USD | 3.12% |
| 2018 Q2 | 192.38 Million USD | 1.5% |
| 2018 FY | 769.49 Million USD | 5.85% |
| 2018 Q3 | 195.82 Million USD | 1.79% |
| 2018 Q4 | 199.81 Million USD | 2.04% |
| 2018 Q1 | 189.53 Million USD | 0.81% |
| 2017 Q3 | 180.65 Million USD | -0.18% |
| 2017 Q2 | 180.97 Million USD | -0.28% |
| 2017 Q1 | 181.49 Million USD | -1.16% |
| 2017 FY | 726.96 Million USD | 3.09% |
| 2017 Q4 | 188 Million USD | 4.07% |
| 2016 Q4 | 183.63 Million USD | 3.77% |
| 2016 Q3 | 176.95 Million USD | 2.5% |
| 2016 Q1 | 171.91 Million USD | -1.17% |
| 2016 FY | 705.15 Million USD | 5.88% |
| 2016 Q2 | 172.64 Million USD | 0.42% |
| 2015 Q1 | 160.15 Million USD | -0.03% |
| 2015 Q3 | 168.18 Million USD | 2.74% |
| 2015 FY | 665.99 Million USD | 10.97% |
| 2015 Q4 | 173.96 Million USD | 3.43% |
| 2015 Q2 | 163.69 Million USD | 2.21% |
| 2014 Q1 | 133.49 Million USD | 2.62% |
| 2014 FY | 600.14 Million USD | 22.32% |
| 2014 Q4 | 160.19 Million USD | 1.63% |
| 2014 Q2 | 148.83 Million USD | 11.49% |
| 2014 Q3 | 157.62 Million USD | 5.91% |
| 2013 Q4 | 130.08 Million USD | 3.13% |
| 2013 Q3 | 126.14 Million USD | 5.13% |
| 2013 Q2 | 119.98 Million USD | 4.86% |
| 2013 FY | 490.64 Million USD | 23.63% |
| 2013 Q1 | 114.42 Million USD | 5.8% |
| 2012 Q1 | 90.04 Million USD | 6.73% |
| 2012 Q2 | 96.88 Million USD | 7.59% |
| 2012 Q3 | 102.17 Million USD | 5.46% |
| 2012 Q4 | 108.15 Million USD | 5.86% |
| 2012 FY | 396.87 Million USD | 18.89% |
| 2011 Q2 | 82.17 Million USD | -3.12% |
| 2011 Q4 | 84.37 Million USD | 2.36% |
| 2011 Q3 | 82.42 Million USD | 0.3% |
| 2011 FY | 333.8 Million USD | -6.93% |
| 2011 Q1 | 84.82 Million USD | -8.14% |
| 2010 Q3 | 85.63 Million USD | -7.8% |
| 2010 Q2 | 92.88 Million USD | 5.8% |
| 2010 Q1 | 87.79 Million USD | -8.67% |
| 2010 FY | 358.65 Million USD | -5.57% |
| 2010 Q4 | 92.34 Million USD | 7.84% |
| 2009 Q4 | 96.12 Million USD | 3.16% |
| 2009 Q1 | 95.66 Million USD | 0.73% |
| 2009 FY | 379.82 Million USD | 1.02% |
| 2009 Q3 | 93.18 Million USD | -1.76% |
| 2009 Q2 | 94.85 Million USD | -0.84% |
| 2008 Q1 | 88.15 Million USD | 9.78% |
| 2008 FY | 376.01 Million USD | 36.12% |
| 2008 Q4 | 94.96 Million USD | -2.66% |
| 2008 Q3 | 97.56 Million USD | 2.35% |
| 2008 Q2 | 95.32 Million USD | 8.13% |
| 2007 Q3 | 75.24 Million USD | 19.1% |
| 2007 FY | 276.24 Million USD | 38.58% |
| 2007 Q1 | 57.53 Million USD | 3.04% |
| 2007 Q4 | 80.29 Million USD | 6.72% |
| 2007 Q2 | 63.17 Million USD | 9.8% |
| 2006 FY | 199.33 Million USD | 0.0% |
| 2006 Q3 | 52.28 Million USD | 10.26% |
| 2006 Q4 | 55.83 Million USD | 6.79% |
| 2006 Q1 | 43.79 Million USD | 11.28% |
| 2006 Q2 | 47.42 Million USD | 8.29% |
| 2005 Q4 | 39.35 Million USD | 1.92% |
| 2005 FY | - USD | -100.0% |
| 2005 Q1 | 36.84 Million USD | 2.86% |
| 2005 Q2 | 38.44 Million USD | 4.32% |
| 2005 Q3 | 38.61 Million USD | 0.44% |
| 2004 FY | 134.36 Million USD | 30.0% |
| 2004 Q2 | 35.62 Million USD | 3.69% |
| 2004 Q3 | 35.88 Million USD | 0.72% |
| 2004 Q4 | 35.82 Million USD | -0.17% |
| 2004 Q1 | 34.36 Million USD | 3.69% |
| 2003 Q1 | 25.94 Million USD | 4.54% |
| 2003 FY | 103.35 Million USD | 41.22% |
| 2003 Q4 | 33.13 Million USD | 6.09% |
| 2003 Q3 | 31.23 Million USD | 0.26% |
| 2003 Q2 | 31.15 Million USD | 20.08% |
| 2002 Q4 | 24.81 Million USD | 15.79% |
| 2002 FY | 73.18 Million USD | 39.76% |
| 2002 Q2 | 20.07 Million USD | 7.69% |
| 2002 Q1 | 18.63 Million USD | 8.4% |
| 2002 Q3 | 21.43 Million USD | 6.79% |
| 2001 Q3 | 17.28 Million USD | 20.62% |
| 2001 Q1 | 13.54 Million USD | 6.45% |
| 2001 Q4 | 17.19 Million USD | -0.5% |
| 2001 Q2 | 14.32 Million USD | 5.79% |
| 2001 FY | 52.36 Million USD | 35.22% |
| 2000 Q3 | 11.75 Million USD | 9.14% |
| 2000 Q4 | 12.72 Million USD | 8.24% |
| 2000 Q2 | 10.76 Million USD | 8.82% |
| 2000 Q1 | 9.89 Million USD | 15.07% |
| 2000 FY | 38.72 Million USD | 46.12% |
| 1999 Q4 | 8.6 Million USD | 4.88% |
| 1999 FY | 26.5 Million USD | -37.05% |
| 1999 Q2 | 14.5 Million USD | -1.36% |
| 1999 Q1 | 14.7 Million USD | 7.3% |
| 1999 Q3 | 8.2 Million USD | -43.45% |
| 1998 Q4 | 13.7 Million USD | 7.03% |
| 1998 Q2 | 12.1 Million USD | 21.0% |
| 1998 Q1 | 10 Million USD | 0.0% |
| 1998 FY | 42.1 Million USD | 0.0% |
| 1998 Q3 | 12.8 Million USD | 5.79% |
| 1997 Q4 | 10 Million USD | 0.0% |
| 1997 Q3 | 10 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | -18865.89% |
| Prenetics Global Limited | 8.82 Million USD | -20447.001% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -15112.787% |
| CareDx, Inc | 178.32 Million USD | -917.399% |
| Exact Sciences Corporation | 1.84 Billion USD | 1.693% |
| Exagen Inc. | 29.45 Million USD | -6059.278% |
| Inotiv, Inc. | 165.44 Million USD | -996.618% |
| Guardant Health, Inc. | 336.89 Million USD | -438.527% |
| Biodesix, Inc. | 36.07 Million USD | -4928.902% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -136363.312% |
| Precipio, Inc. | 6.01 Million USD | -30047.507% |
| iSpecimen Inc. | 5.1 Million USD | -35418.928% |
| Natera, Inc. | 492.74 Million USD | -268.202% |
| Aspira Women's Health Inc. | 5.26 Million USD | -34378.848% |
| Standard BioTools Inc. | 50.45 Million USD | -3496.188% |
| 23andMe Holding Co. | 99.37 Million USD | -1725.651% |
| Castle Biosciences, Inc. | 174.8 Million USD | -937.88% |
| Personalis, Inc. | 18.2 Million USD | -9864.175% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -13677.924% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -32687.554% |
| OpGen, Inc. | -90.69 Thousand USD | 2000537.736% |
| T2 Biosystems, Inc. | -8.17 Million USD | 22306.573% |
| Myriad Genetics, Inc. | 476.4 Million USD | -280.831% |
| NeoGenomics, Inc. | 244.6 Million USD | -641.72% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -15112.787% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 17.155% |
| RadNet, Inc. | 93 Million USD | -1850.835% |
| MDxHealth SA | 43.92 Million USD | -4030.021% |
| Psychemedics Corporation | 8.41 Million USD | -21465.161% |
| Illumina, Inc. | 2.74 Billion USD | 33.882% |
| Check-Cap Ltd. | -212 Thousand USD | 855891.038% |
| Twist Bioscience Corporation | 133.34 Million USD | -1260.548% |
| DarioHealth Corp. | 5.98 Million USD | -30218.8% |
| Fulgent Genetics, Inc. | 104.45 Million USD | -1636.882% |
| Sera Prognostics, Inc. | 96 Thousand USD | -1889771.875% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 658756.894% |
| OPKO Health, Inc. | 318.12 Million USD | -470.3% |
| Medpace Holdings, Inc. | 524.5 Million USD | -245.903% |
| Neogen Corporation | 463.9 Million USD | -291.092% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -127161.778% |
| Prenetics Global Limited | 8.82 Million USD | -20447.001% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -355878.605% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -229086.789% |
| Trinity Biotech plc | 19.45 Million USD | -9227.902% |
| Neuronetics, Inc. | 51.7 Million USD | -3408.9% |
| Sotera Health Company | 577.15 Million USD | -214.347% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -229086.789% |